Paolo Spallarossa

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Multidisciplinary therapy managements in endometrial and renal cancer patients treated with pembrolizumab and lenvatinib: a virtuous circle between oncologists and organ specialists.

Multidisciplinary therapy managements in endometrial and renal cancer patients treated with pembrolizumab and lenvatinib: a virtuous circle between oncologists and organ specialists.

Journal: Critical reviews in oncology/hematology

Published: May 27, 2025

Practical considerations about management of pulmonary embolism in patients with cancer.

Practical considerations about management of pulmonary embolism in patients with cancer.

Journal: Journal of thrombosis and thrombolysis

Published: May 26, 2025

Pericardial effusion in oncological patients: current knowledge and principles of management.

Pericardial effusion in oncological patients: current knowledge and principles of management.

Journal: Cardio-oncology (London, England)

Published: January 02, 2024

Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers.

Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers.

Journal: Current problems in cardiology

Published: November 19, 2023

Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies.

Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies.

Journal: Current treatment options in oncology

Published: November 12, 2023

A contemporary update on cancer and takotsubo syndrome.

A contemporary update on cancer and takotsubo syndrome.

Journal: Frontiers in cardiovascular medicine

Published: September 24, 2023

Reply to Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane.

Reply to Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane.

Journal: Pediatric blood & cancer

Published: September 01, 2023

Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study.

Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study.

Journal: British journal of haematology

Published: August 28, 2023

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism.

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism.

Journal: Current oncology reports

Published: May 02, 2023

Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis.

Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis.

Journal: Current oncology reports

Published: March 21, 2023

Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies.

Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies.

Journal: Current heart failure reports

Published: November 30, 2022

Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane.

Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane.

Journal: Pediatric blood & cancer

Published: November 10, 2022

Showing 1-12 of 67

Last Updated: 09/26/2026